Modulating BAP1 expression affects ROS homeostasis, cell motility and mitochondrial function
Lucie Hebert1, Dorine Bellanger1, Chloé Guillas1
1Department of Genetics and Biology of Cancers, INSERM U830, Institut Curie, PSL Research University, Paris 75248, France.
Abstract:
The tumor suppressor BAP1 associates with ASXL1/2 to form the core Polycomb complex PR-DUB, which catalyzes the removal of mono-ubiquitin from several substrates including histone H2A. This complex also mediates the poly-deubiquitination of HCFC1, OGT and PCG1-α, preventing them from proteasomal degradation. Surprisingly, considering its role in a Polycomb complex, no transcriptional signature was consistently found among BAP1-inactivated tumor types. It was hypothesized that BAP1 tumor suppressor activity could reside, at least in part, in stabilizing proteins through its poly-deubiquitinase activity. Quantitative mass spectrometry and gene expression arrays were used to investigate the consequences of BAP1 expression modulation in the NCI-H226 mesothelioma cell line. Analysis of differentially expressed proteins revealed enrichment in cytoskeleton organization, mitochondrial activity and ROS management, while gene expression analysis revealed enrichment in the epithelial-to-mesenchymal transition pathway. Functional assessments in BAP1 inactivated, BAP1 wild-type and BAP1 catalytically dead-expressing NCI-H226 and QR mesothelioma cell lines confirmed alteration of these pathways and demonstrated that BAP1 deubiquitinase activity was mandatory to maintain these phenotypes. Interestingly, monitoring intracellular ROS levels partly restored the morphology and the mitochondrial activity. Finally, the study suggests new tumorigenic and cellular functions of BAP1 and shows for the first time the interest of studying the proteome as readout of BAP1 inactivation.
Insights
The BAP1 tumor suppressor protein stabilizes other proteins via its deubiquitinase activity, impacting cytoskeleton, mitochondria, and ROS levels. This proteomic approach reveals novel BAP1 functions in cancer.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- The BAP1 (BRCA1-associated protein 1) gene product is a key component of the PR-DUB complex, involved in histone modification and protein deubiquitination.
- Despite its role in a Polycomb complex, transcriptional changes are not consistently observed in BAP1-inactivated tumors, suggesting alternative mechanisms of tumor suppression.
- BAP1's tumor suppressor activity may involve protein stabilization through its deubiquitinase function, independent of canonical transcriptional regulation.
Purpose of the Study:
- To investigate the functional consequences of BAP1 inactivation and its deubiquitinase activity on cellular proteomes and pathways.
- To explore the hypothesis that BAP1 stabilizes proteins, thereby exerting its tumor suppressor functions.
- To identify novel cellular and tumorigenic roles of BAP1 and validate proteomic analysis as a readout for BAP1 inactivation.
Main Methods:
- Quantitative mass spectrometry was employed to analyze protein expression changes.
- Gene expression arrays were used to assess transcriptomic alterations.
- Functional assays were performed in mesothelioma cell lines with varying BAP1 expression (inactivated, wild-type, catalytically dead).
Main Results:
- Proteomic analysis revealed significant alterations in cytoskeleton organization, mitochondrial activity, and reactive oxygen species (ROS) management upon BAP1 modulation.
- Gene expression profiling indicated enrichment in the epithelial-to-mesenchymal transition (EMT) pathway.
- Functional studies confirmed that BAP1's deubiquitinase activity is essential for maintaining these cellular phenotypes, and ROS modulation partially restored cellular functions.
Conclusions:
- BAP1 plays a crucial role in regulating cellular morphology, mitochondrial function, and ROS homeostasis, likely through its protein stabilization activity.
- BAP1's deubiquitinase activity is mandatory for maintaining these cellular phenotypes, highlighting a non-transcriptional mechanism of tumor suppression.
- Proteomic profiling offers a valuable approach to understanding the impact of BAP1 inactivation in cancer and identifying novel therapeutic targets.
More Related Videos
Related Concept Videos
Cell Motility through Blebbing
Blebbing Through the Matrix
In multicellular...
Mitochondrial Membranes
Mechanisms of Membrane-bending
Membrane bending can happen due to intrinsic changes in lipid composition or extrinsic association with different proteins. The proteins involved...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway


